We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
+8.02%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.89B
AUM Growth
+$232M
Cap. Flow
+$22.2M
Cap. Flow %
0.45%
Top 10 Hldgs %
7.1%
Holding
1,417
New
62
Increased
609
Reduced
305
Closed
113

Top Buys

Rank Stock Value
1
MBC icon
MasterBrand
MBC
+$17.7M
2
MLKN icon
MillerKnoll
MLKN
+$17.4M
3
VYX icon
NCR Voyix
VYX
+$14.9M
4
RTX icon
RTX Corp
RTX
+$8.92M
5
COST icon
Costco
COST
+$7.64M

Top Sells

Rank Stock Value
1
ARCB icon
ArcBest
ARCB
+$19.4M
2
NVDA icon
NVIDIA
NVDA
+$19.4M
3
CHS
Chicos FAS, Inc.
CHS
+$11.7M
4
AROC icon
Archrock
AROC
+$11.3M
5
CTRA
Coterra Energy
CTRA
+$7.93M

Sector Composition

Rank Sector Weight
1 Financials 25.84%
2 Consumer Discretionary 12.72%
3 Industrials 12.57%
4 Technology 11.39%
5 Energy 8.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TOVX icon
1376
Theriva Biologics
TOVX
$10.1M
-1,141
Closed -$12.3K
TPET icon
1377
Trio Petroleum
TPET
$10.4M
-1,185
Closed -$7.34K
VRM icon
1378
Vroom Inc
VRM
$48.2M
-1,250
Closed -$60.3K
VTYX
1379
DELISTED
Ventyx Biosciences
VTYX
-710,800
Closed -$1.76M
WFG icon
1380
West Fraser Timber
WFG
$5.65B
-31,200
Closed -$2.67M
XERS icon
1381
Xeris Biopharma Holdings
XERS
$1.45B
-14,100
Closed -$33.1K
SER icon
1382
Serina Therapeutics
SER
$36M
-4,116
Closed -$55.7K
CNR
1383
Core Natural Resources Inc
CNR
$4.45B
-49,195
Closed -$4.95M
OKUR
1384
OnKure Therapeutics
OKUR
$168M
-9,138
Closed -$146K
TVRD
1385
Tvardi Therapeutics
TVRD
$23.4M
-3,922
Closed -$105K
AUMN
1386
DELISTED
Golden Minerals Company
AUMN
-18,000
Closed -$9.36K
PRST
1387
DELISTED
Presto Technologies, Inc. Common Stock
PRST
-155,000
Closed -$82.4K
TWOU
1388
DELISTED
2U Inc
TWOU
-24,813
Closed -$916K
CAMP
1389
DELISTED
CalAmp Corp.
CAMP
-5,003
Closed -$28.9K
ZFOX
1390
DELISTED
ZeroFox Holdings, Inc. Common Stock
ZFOX
-244,900
Closed -$213K
NGM
1391
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-195,000
Closed -$168K
KNTE
1392
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
-91,300
Closed -$216K
MVLA
1393
DELISTED
Movella Holdings Inc. Common Stock
MVLA
-121,500
Closed -$73.5K
DSKE
1394
DELISTED
Daseke, Inc. Common Stock
DSKE
-164,469
Closed -$1.33M
JOAN
1395
DELISTED
JOANN, Inc. Common Stock
JOAN
-125,000
Closed -$55.8K
BCEL
1396
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-75,000
Closed -$9.9K
CYT
1397
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
-32,800
Closed -$99.7K
TGH
1398
DELISTED
Textainer Group Holdings limited
TGH
-111,200
Closed -$5.47M
CURO
1399
DELISTED
CURO Group Holdings Corp.
CURO
-105,167
Closed -$84.1K
BFX
1400
DELISTED
BowFlex Inc.
BFX
-221,400
Closed -$170K

Similar funds

Bridgeway Capital Management's Q1 2024 Portfolio in Review

As of Q1 2024, Bridgeway Capital Management held 1,417 positions worth $4.89B, up 5% from $4.66B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.

Bridgeway Capital Management's Q1 2024 filing shows 62 new, 609 increased, 305 reduced and 113 closed positions. Its largest new stake was MasterBrand: 1,114,946 shares worth $20.9M. The largest sale was ArcBest, an estimated $19.4M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Consumer Discretionary and Industrials.

  • Bridgeway Capital Management's largest Q1 2024 buy was MasterBrand: 1,114,946 shares worth $20.9M.
  • Bridgeway Capital Management added most to RTX Corp in Q1 2024, an estimated $8.92M increase.
  • Bridgeway Capital Management's biggest Q1 2024 reduction was ArcBest, cutting an estimated $19.4M.
  • Bridgeway Capital Management fully exited Chicos FAS, Inc. in Q1 2024, selling an estimated $11.7M.
  • Bridgeway Capital Management's ten largest holdings make up 7.1% of its $4.89B portfolio in Q1 2024.
  • Bridgeway Capital Management opened 62 new positions and closed 113 in Q1 2024.
  • Bridgeway Capital Management's portfolio value rose 5% quarter-over-quarter to $4.89B.

Based on Bridgeway Capital Management's 13F filing for Q1 2024, filed 15 May 2024.